drugset / Trial / NCT00930306
AZD2066 Cocktail Study
RandomizedSingle-groupOpen-label
Summary
The aims of this study are to examine the effect of repeated doses of AZD2066 and of caffeine, bupropion, tolbutamide, omeprazole, metoprolol and midazolam on the blood concentrations of each other
Timeline
- Start
- 2009-06
- Primary completion
- —
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD2066 | Small molecule | 8 mg | Oral |
| Subject | Caffeine | Small molecule | 100 mg | Oral |
| Subject | Midazolam | Small molecule | 7.5 mg | Oral |
| Subject | Omeprazole | Other / unclassified | 20 mg | Oral |
| Subject | Tolbutamide | Small molecule | 250 mg | Oral |